Media stories about Dynatronics (NASDAQ:DYNT) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dynatronics earned a news sentiment score of 0.02 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 47.008364899704 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the media stories that may have impacted Accern Sentiment’s rankings:
- Reviewing CONMED (CNMD) & Dynatronics (DYNT) (americanbankingnews.com)
- Dynatronics Corporation: Dynatronics to Attend NATA Show (finanznachrichten.de)
- Head-To-Head Contrast: Edap Tms (EDAP) versus Dynatronics (DYNT) (americanbankingnews.com)
Dynatronics traded up $0.05, hitting $3.05, during midday trading on Friday, Marketbeat.com reports. The company’s stock had a trading volume of 511 shares, compared to its average volume of 4,407. The company has a current ratio of 1.62, a quick ratio of 0.70 and a debt-to-equity ratio of 0.32. Dynatronics has a 12 month low of $2.10 and a 12 month high of $3.55. The stock has a market cap of $24.27 million, a PE ratio of -2.65 and a beta of -0.60.
Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings results on Tuesday, May 15th. The medical equipment provider reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.03. The firm had revenue of $16.63 million for the quarter. Dynatronics had a negative net margin of 3.06% and a negative return on equity of 10.31%. equities analysts predict that Dynatronics will post -0.4 EPS for the current fiscal year.
Several equities research analysts have commented on DYNT shares. Zacks Investment Research upgraded shares of Dynatronics from a “sell” rating to a “hold” rating in a research report on Friday, April 27th. ValuEngine upgraded shares of Dynatronics from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd.
Dynatronics Corporation designs, manufactures, distributes, and markets physical medicine products in the United States and internationally. It manufactures and sells electrotherapy, therapeutic ultrasound, phototherapy, thermal therapy, iontophoresis devices, and other modalities; traction therapy equipment; and medical supplies and soft goods, including hot and cold packs, lumbar rolls, exercise balls, wrist splints, ankle weights, cervical collars and pillows, slings, bolsters, positioning wedges, back cushions, weight racks, rehabilitation products, back and wrist braces.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.